The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant DNA Technology Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Recombinant DNA Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant DNA Technology market size is estimated to be worth US$ 505 million in 2021 and is forecast to a readjusted size of USD 653.1 million by 2028 with a CAGR of 3.7% during review period. Biotechnology and Pharmaceutical Companies accounting for % of the Recombinant DNA Technology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Therapeutic Agent segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant DNA Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market segment by Application, can be divided into
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Market segment by players, this report covers
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Recombinant DNA Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant DNA Technology, with revenue, gross margin and global market share of Recombinant DNA Technology from 2019 to 2022.
Chapter 3, the Recombinant DNA Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant DNA Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant DNA Technology research findings and conclusion, appendix and data source.
Geographical Area
Global
The Recombinant DNA Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant DNA Technology market size is estimated to be worth US$ 505 million in 2021 and is forecast to a readjusted size of USD 653.1 million by 2028 with a CAGR of 3.7% during review period. Biotechnology and Pharmaceutical Companies accounting for % of the Recombinant DNA Technology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Therapeutic Agent segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant DNA Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Market segment by Application, can be divided into
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Market segment by players, this report covers
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Recombinant DNA Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant DNA Technology, with revenue, gross margin and global market share of Recombinant DNA Technology from 2019 to 2022.
Chapter 3, the Recombinant DNA Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant DNA Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant DNA Technology research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Recombinant DNA Technology
1.2 Classification of Recombinant DNA Technology by Type
1.2.1 Overview: Global Recombinant DNA Technology Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Recombinant DNA Technology Revenue Market Share by Type in 2021
1.2.3 Therapeutic Agent
1.2.4 Vaccine
1.2.5 Biotech Crops
1.2.6 Specialty Chemicals
1.3 Global Recombinant DNA Technology Market by Application
1.3.1 Overview: Global Recombinant DNA Technology Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Global Recombinant DNA Technology Market Size & Forecast
1.5 Global Recombinant DNA Technology Market Size and Forecast by Region
1.5.1 Global Recombinant DNA Technology Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Recombinant DNA Technology Market Size by Region, (2017-2022)
1.5.3 North America Recombinant DNA Technology Market Size and Prospect (2017-2028)
1.5.4 Europe Recombinant DNA Technology Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Recombinant DNA Technology Market Size and Prospect (2017-2028)
1.5.6 South America Recombinant DNA Technology Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Recombinant DNA Technology Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant DNA Technology Market Drivers
1.6.2 Recombinant DNA Technology Market Restraints
1.6.3 Recombinant DNA Technology Trends Analysis
2 Company Profiles
2.1 Monsanto Company
2.1.1 Monsanto Company Details
2.1.2 Monsanto Company Major Business
2.1.3 Monsanto Company Recombinant DNA Technology Product and Solutions
2.1.4 Monsanto Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Monsanto Company Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Recombinant DNA Technology Product and Solutions
2.2.4 Roche Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Recombinant DNA Technology Product and Solutions
2.3.4 Biogen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Recombinant DNA Technology Product and Solutions
2.4.4 Amgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Recombinant DNA Technology Product and Solutions
2.5.4 Novartis Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Recombinant DNA Technology Product and Solutions
2.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly and Company Recent Developments and Future Plans
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Recombinant DNA Technology Product and Solutions
2.7.4 GenScript Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GenScript Recent Developments and Future Plans
2.8 Pfizer Inc.
2.8.1 Pfizer Inc. Details
2.8.2 Pfizer Inc. Major Business
2.8.3 Pfizer Inc. Recombinant DNA Technology Product and Solutions
2.8.4 Pfizer Inc. Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pfizer Inc. Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Recombinant DNA Technology Product and Solutions
2.9.4 Novo Nordisk Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Novo Nordisk Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Recombinant DNA Technology Product and Solutions
2.10.4 Sanofi Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Recombinant DNA Technology Product and Solutions
2.11.4 Merck KGaA Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Profacgen
2.12.1 Profacgen Details
2.12.2 Profacgen Major Business
2.12.3 Profacgen Recombinant DNA Technology Product and Solutions
2.12.4 Profacgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Profacgen Recent Developments and Future Plans
2.13 Biocon
2.13.1 Biocon Details
2.13.2 Biocon Major Business
2.13.3 Biocon Recombinant DNA Technology Product and Solutions
2.13.4 Biocon Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Biocon Recent Developments and Future Plans
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Recombinant DNA Technology Product and Solutions
2.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 GlaxoSmithKline Recent Developments and Future Plans
2.15 Cibus
2.15.1 Cibus Details
2.15.2 Cibus Major Business
2.15.3 Cibus Recombinant DNA Technology Product and Solutions
2.15.4 Cibus Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Cibus Recent Developments and Future Plans
2.16 Horizon Discovery Group
2.16.1 Horizon Discovery Group Details
2.16.2 Horizon Discovery Group Major Business
2.16.3 Horizon Discovery Group Recombinant DNA Technology Product and Solutions
2.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Horizon Discovery Group Recent Developments and Future Plans
2.17 New England Biolabs
2.17.1 New England Biolabs Details
2.17.2 New England Biolabs Major Business
2.17.3 New England Biolabs Recombinant DNA Technology Product and Solutions
2.17.4 New England Biolabs Recombinant DNA Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 New England Biolabs Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant DNA Technology Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant DNA Technology Players Market Share in 2021
3.2.2 Top 10 Recombinant DNA Technology Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Recombinant DNA Technology Players Head Office, Products and Services Provided
3.4 Recombinant DNA Technology Mergers & Acquisitions
3.5 Recombinant DNA Technology New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Recombinant DNA Technology Revenue and Market Share by Type (2017-2022)
4.2 Global Recombinant DNA Technology Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Recombinant DNA Technology Revenue Market Share by Application (2017-2022)
5.2 Global Recombinant DNA Technology Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Recombinant DNA Technology Revenue by Type (2017-2028)
6.2 North America Recombinant DNA Technology Revenue by Application (2017-2028)
6.3 North America Recombinant DNA Technology Market Size by Country
6.3.1 North America Recombinant DNA Technology Revenue by Country (2017-2028)
6.3.2 United States Recombinant DNA Technology Market Size and Forecast (2017-2028)
6.3.3 Canada Recombinant DNA Technology Market Size and Forecast (2017-2028)
6.3.4 Mexico Recombinant DNA Technology Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Recombinant DNA Technology Revenue by Type (2017-2028)
7.2 Europe Recombinant DNA Technology Revenue by Application (2017-2028)
7.3 Europe Recombinant DNA Technology Market Size by Country
7.3.1 Europe Recombinant DNA Technology Revenue by Country (2017-2028)
7.3.2 Germany Recombinant DNA Technology Market Size and Forecast (2017-2028)
7.3.3 France Recombinant DNA Technology Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Recombinant DNA Technology Market Size and Forecast (2017-2028)
7.3.5 Russia Recombinant DNA Technology Market Size and Forecast (2017-2028)
7.3.6 Italy Recombinant DNA Technology Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Recombinant DNA Technology Revenue by Type (2017-2028)
8.2 Asia-Pacific Recombinant DNA Technology Revenue by Application (2017-2028)
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Region
8.3.1 Asia-Pacific Recombinant DNA Technology Revenue by Region (2017-2028)
8.3.2 China Recombinant DNA Technology Market Size and Forecast (2017-2028)
8.3.3 Japan Recombinant DNA Technology Market Size and Forecast (2017-2028)
8.3.4 South Korea Recombinant DNA Technology Market Size and Forecast (2017-2028)
8.3.5 India Recombinant DNA Technology Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Recombinant DNA Technology Market Size and Forecast (2017-2028)
8.3.7 Australia Recombinant DNA Technology Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Recombinant DNA Technology Revenue by Type (2017-2028)
9.2 South America Recombinant DNA Technology Revenue by Application (2017-2028)
9.3 South America Recombinant DNA Technology Market Size by Country
9.3.1 South America Recombinant DNA Technology Revenue by Country (2017-2028)
9.3.2 Brazil Recombinant DNA Technology Market Size and Forecast (2017-2028)
9.3.3 Argentina Recombinant DNA Technology Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Recombinant DNA Technology Revenue by Type (2017-2028)
10.2 Middle East & Africa Recombinant DNA Technology Revenue by Application (2017-2028)
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Country
10.3.1 Middle East & Africa Recombinant DNA Technology Revenue by Country (2017-2028)
10.3.2 Turkey Recombinant DNA Technology Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Recombinant DNA Technology Market Size and Forecast (2017-2028)
10.3.4 UAE Recombinant DNA Technology Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant DNA Technology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Recombinant DNA Technology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Recombinant DNA Technology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Recombinant DNA Technology Revenue (USD Million) by Region (2017-2022)
Table 5. Global Recombinant DNA Technology Revenue Market Share by Region (2023-2028)
Table 6. Monsanto Company Corporate Information, Head Office, and Major Competitors
Table 7. Monsanto Company Major Business
Table 8. Monsanto Company Recombinant DNA Technology Product and Solutions
Table 9. Monsanto Company Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Recombinant DNA Technology Product and Solutions
Table 13. Roche Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Biogen Corporate Information, Head Office, and Major Competitors
Table 15. Biogen Major Business
Table 16. Biogen Recombinant DNA Technology Product and Solutions
Table 17. Biogen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Amgen Corporate Information, Head Office, and Major Competitors
Table 19. Amgen Major Business
Table 20. Amgen Recombinant DNA Technology Product and Solutions
Table 21. Amgen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Recombinant DNA Technology Product and Solutions
Table 25. Novartis Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly and Company Major Business
Table 28. Eli Lilly and Company Recombinant DNA Technology Product and Solutions
Table 29. Eli Lilly and Company Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GenScript Corporate Information, Head Office, and Major Competitors
Table 31. GenScript Major Business
Table 32. GenScript Recombinant DNA Technology Product and Solutions
Table 33. GenScript Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Inc. Major Business
Table 36. Pfizer Inc. Recombinant DNA Technology Product and Solutions
Table 37. Pfizer Inc. Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 39. Novo Nordisk Major Business
Table 40. Novo Nordisk Recombinant DNA Technology Product and Solutions
Table 41. Novo Nordisk Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi Major Business
Table 44. Sanofi Recombinant DNA Technology Product and Solutions
Table 45. Sanofi Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 47. Merck KGaA Major Business
Table 48. Merck KGaA Recombinant DNA Technology Product and Solutions
Table 49. Merck KGaA Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Profacgen Corporate Information, Head Office, and Major Competitors
Table 51. Profacgen Major Business
Table 52. Profacgen Recombinant DNA Technology Product and Solutions
Table 53. Profacgen Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Biocon Corporate Information, Head Office, and Major Competitors
Table 55. Biocon Major Business
Table 56. Biocon Recombinant DNA Technology Product and Solutions
Table 57. Biocon Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 59. GlaxoSmithKline Major Business
Table 60. GlaxoSmithKline Recombinant DNA Technology Product and Solutions
Table 61. GlaxoSmithKline Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Cibus Corporate Information, Head Office, and Major Competitors
Table 63. Cibus Major Business
Table 64. Cibus Recombinant DNA Technology Product and Solutions
Table 65. Cibus Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 67. Horizon Discovery Group Major Business
Table 68. Horizon Discovery Group Recombinant DNA Technology Product and Solutions
Table 69. Horizon Discovery Group Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 71. New England Biolabs Major Business
Table 72. New England Biolabs Recombinant DNA Technology Product and Solutions
Table 73. New England Biolabs Recombinant DNA Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Recombinant DNA Technology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Recombinant DNA Technology Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Recombinant DNA Technology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Recombinant DNA Technology Players Head Office, Products and Services Provided
Table 78. Recombinant DNA Technology Mergers & Acquisitions in the Past Five Years
Table 79. Recombinant DNA Technology New Entrants and Expansion Plans
Table 80. Global Recombinant DNA Technology Revenue (USD Million) by Type (2017-2022)
Table 81. Global Recombinant DNA Technology Revenue Share by Type (2017-2022)
Table 82. Global Recombinant DNA Technology Revenue Forecast by Type (2023-2028)
Table 83. Global Recombinant DNA Technology Revenue by Application (2017-2022)
Table 84. Global Recombinant DNA Technology Revenue Forecast by Application (2023-2028)
Table 85. North America Recombinant DNA Technology Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Recombinant DNA Technology Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Recombinant DNA Technology Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Recombinant DNA Technology Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Recombinant DNA Technology Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Recombinant DNA Technology Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Recombinant DNA Technology Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Recombinant DNA Technology Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Recombinant DNA Technology Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Recombinant DNA Technology Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Recombinant DNA Technology Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Recombinant DNA Technology Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Recombinant DNA Technology Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Recombinant DNA Technology Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Recombinant DNA Technology Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Recombinant DNA Technology Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Recombinant DNA Technology Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Recombinant DNA Technology Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Recombinant DNA Technology Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Recombinant DNA Technology Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Recombinant DNA Technology Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Recombinant DNA Technology Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Recombinant DNA Technology Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Recombinant DNA Technology Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Recombinant DNA Technology Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Recombinant DNA Technology Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Recombinant DNA Technology Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Recombinant DNA Technology Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Recombinant DNA Technology Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Recombinant DNA Technology Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Recombinant DNA Technology Picture
Figure 2. Global Recombinant DNA Technology Revenue Market Share by Type in 2021
Figure 3. Therapeutic Agent
Figure 4. Vaccine
Figure 5. Biotech Crops
Figure 6. Specialty Chemicals
Figure 7. Recombinant DNA Technology Revenue Market Share by Application in 2021
Figure 8. Biotechnology and Pharmaceutical Companies Picture
Figure 9. Academic & Government Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global Recombinant DNA Technology Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Recombinant DNA Technology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Recombinant DNA Technology Revenue Market Share by Region (2017-2028)
Figure 14. Global Recombinant DNA Technology Revenue Market Share by Region in 2021
Figure 15. North America Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Recombinant DNA Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Recombinant DNA Technology Market Drivers
Figure 21. Recombinant DNA Technology Market Restraints
Figure 22. Recombinant DNA Technology Market Trends
Figure 23. Monsanto Company Recent Developments and Future Plans
Figure 24. Roche Recent Developments and Future Plans
Figure 25. Biogen Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Eli Lilly and Company Recent Developments and Future Plans
Figure 29. GenScript Recent Developments and Future Plans
Figure 30. Pfizer Inc. Recent Developments and Future Plans
Figure 31. Novo Nordisk Recent Developments and Future Plans
Figure 32. Sanofi Recent Developments and Future Plans
Figure 33. Merck KGaA Recent Developments and Future Plans
Figure 34. Profacgen Recent Developments and Future Plans
Figure 35. Biocon Recent Developments and Future Plans
Figure 36. GlaxoSmithKline Recent Developments and Future Plans
Figure 37. Cibus Recent Developments and Future Plans
Figure 38. Horizon Discovery Group Recent Developments and Future Plans
Figure 39. New England Biolabs Recent Developments and Future Plans
Figure 40. Global Recombinant DNA Technology Revenue Share by Players in 2021
Figure 41. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Recombinant DNA Technology Revenue Market Share in 2021
Figure 43. Global Top 10 Players Recombinant DNA Technology Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Recombinant DNA Technology Revenue Share by Type in 2021
Figure 46. Global Recombinant DNA Technology Market Share Forecast by Type (2023-2028)
Figure 47. Global Recombinant DNA Technology Revenue Share by Application in 2021
Figure 48. Global Recombinant DNA Technology Market Share Forecast by Application (2023-2028)
Figure 49. North America Recombinant DNA Technology Sales Market Share by Type (2017-2028)
Figure 50. North America Recombinant DNA Technology Sales Market Share by Application (2017-2028)
Figure 51. North America Recombinant DNA Technology Revenue Market Share by Country (2017-2028)
Figure 52. United States Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Recombinant DNA Technology Sales Market Share by Type (2017-2028)
Figure 56. Europe Recombinant DNA Technology Sales Market Share by Application (2017-2028)
Figure 57. Europe Recombinant DNA Technology Revenue Market Share by Country (2017-2028)
Figure 58. Germany Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Recombinant DNA Technology Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Recombinant DNA Technology Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Recombinant DNA Technology Revenue Market Share by Region (2017-2028)
Figure 66. China Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Recombinant DNA Technology Sales Market Share by Type (2017-2028)
Figure 73. South America Recombinant DNA Technology Sales Market Share by Application (2017-2028)
Figure 74. South America Recombinant DNA Technology Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Recombinant DNA Technology Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Recombinant DNA Technology Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Recombinant DNA Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
